![PDF) Determination of Selenium in Common and Selenium-Rich Rice from Different Areas in China and Assessment of Their Dietary Intake PDF) Determination of Selenium in Common and Selenium-Rich Rice from Different Areas in China and Assessment of Their Dietary Intake](https://i1.rgstatic.net/publication/342526802_Determination_of_Selenium_in_Common_and_Selenium-Rich_Rice_from_Different_Areas_in_China_and_Assessment_of_Their_Dietary_Intake/links/5ef9de54a6fdcc4ca43a3664/largepreview.png)
PDF) Determination of Selenium in Common and Selenium-Rich Rice from Different Areas in China and Assessment of Their Dietary Intake
![PDF) Disease characteristics and treatment patterns of Chinese patients with metastatic colorectal cancer: a retrospective study using medical records from China PDF) Disease characteristics and treatment patterns of Chinese patients with metastatic colorectal cancer: a retrospective study using medical records from China](https://i1.rgstatic.net/publication/339340613_Disease_characteristics_and_treatment_patterns_of_Chinese_patients_with_metastatic_colorectal_cancer_a_retrospective_study_using_medical_records_from_China/links/5fc21a91299bf104cf8801c6/largepreview.png)
PDF) Disease characteristics and treatment patterns of Chinese patients with metastatic colorectal cancer: a retrospective study using medical records from China
Enhanced Tumor-Specific Disulfiram Chemotherapy by In Situ Cu2+ Chelation-Initiated Nontoxicity-to-Toxicity Transition | Journal of the American Chemical Society
Nitrogen heterocycle-containing materials for highly efficient phosphorescent OLEDs with low operating voltage
Paclitaxel enhances tumoricidal potential of TRAIL via inhibition of MAPK in resistant gastric cancer cells
![Randomized, double-blinded, placebo-controlled phase I study of the pharmacokinetics, pharmacodynamics, and safety of KL130008, a novel oral JAK inhibitor, in healthy subjects,European Journal of Pharmaceutical Sciences - X-MOL Randomized, double-blinded, placebo-controlled phase I study of the pharmacokinetics, pharmacodynamics, and safety of KL130008, a novel oral JAK inhibitor, in healthy subjects,European Journal of Pharmaceutical Sciences - X-MOL](https://xpic.x-mol.com/20220711%2F10.1016_j.ejps.2022.106257.jpg)